N Yamamoto Selected Research

N Yamamoto Research Topics

Disease

42	Neoplasms (Cancer) 08/2021 - 01/2000
29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2000
17	Infections 04/2014 - 01/2000
11	Neoplasm Metastasis (Metastasis) 07/2014 - 02/2000
8	Lung Neoplasms (Lung Cancer) 11/2017 - 02/2000
8	Neutropenia 11/2017 - 09/2000
7	Breast Neoplasms (Breast Cancer) 07/2018 - 01/2000
7	Glioma (Gliomas) 02/2009 - 01/2000
6	Disease Progression 01/2021 - 12/2000
6	Body Weight (Weight, Body) 04/2019 - 09/2003
6	Squamous Cell Carcinoma of Head and Neck 05/2017 - 04/2000
5	Sarcoma (Soft Tissue Sarcoma) 08/2021 - 05/2000
5	Carcinogenesis 04/2019 - 04/2001
5	Leukopenia 11/2017 - 08/2001
5	Asthma (Bronchial Asthma) 12/2011 - 11/2000
5	T-Cell Leukemia (Leukemia, T Cell) 12/2001 - 09/2000
5	Inflammation (Inflammations) 06/2001 - 04/2000
4	Colorectal Neoplasms (Colorectal Cancer) 04/2016 - 08/2002
4	Hepatocellular Carcinoma (Hepatoma) 01/2012 - 07/2000
4	Ischemia 10/2001 - 02/2000
3	Nausea 11/2017 - 11/2013
3	Schizophrenia (Dementia Praecox) 10/2015 - 06/2010
3	Exanthema (Rash) 11/2013 - 09/2006
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013 - 03/2004
3	Carcinoma (Carcinomatosis) 06/2010 - 04/2000
3	Atopic Dermatitis (Atopic Eczema) 12/2006 - 11/2003
3	Hypersensitivity (Allergy) 11/2000 - 04/2000
2	Rectal Neoplasms (Rectal Cancer) 05/2019 - 01/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2017 - 05/2001
2	Abscess 05/2017 - 02/2005
2	Wounds and Injuries (Trauma) 01/2017 - 06/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 08/2004
2	Febrile Neutropenia 01/2017 - 10/2015
2	Pneumonia (Pneumonitis) 01/2017 - 07/2002
2	Adenocarcinoma of Lung 11/2016 - 10/2014
2	Anemia 10/2015 - 06/2013
2	Atrophy 09/2015 - 09/2013
2	Erythema 09/2015 - 01/2005
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2014 - 11/2012
2	Hepatitis 04/2014 - 05/2000
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2014 - 03/2001
2	Hypertension (High Blood Pressure) 04/2014 - 05/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2014 - 07/2005
2	Rheumatoid Arthritis 03/2014 - 01/2001
2	Type 2 Diabetes Mellitus (MODY) 10/2013 - 10/2013
2	Anorexia 06/2013 - 04/2012
2	Adenocarcinoma 06/2013 - 04/2001
2	Thymoma (Thymic Carcinoma) 01/2012 - 01/2001

Drug/Important Bio-Agent (IBA)

12	Messenger RNA (mRNA)IBA 10/2015 - 07/2000
10	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 09/2000
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 10/2001
7	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2003
7	Docetaxel (Taxotere)FDA Link 12/2019 - 08/2001
7	Peptides (Polypeptides)IBA 10/2004 - 01/2000
6	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 10/2001
6	Pharmaceutical PreparationsIBA 04/2014 - 02/2000
6	NF-kappa B (NF-kB)IBA 06/2001 - 01/2000
5	Tyrosine Kinase InhibitorsIBA 12/2019 - 06/2003
5	Gefitinib (Iressa)FDA Link 12/2019 - 06/2003
5	Proteins (Proteins, Gene)FDA Link 10/2015 - 05/2000
5	Biomarkers (Surrogate Marker)IBA 01/2014 - 01/2012
5	Chemokine ReceptorsIBA 08/2001 - 12/2000
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 04/2012
4	DNA (Deoxyribonucleic Acid)IBA 03/2011 - 04/2000
4	Irinotecan (Camptosar)FDA LinkGeneric 02/2009 - 07/2002
4	T140 peptideIBA 08/2001 - 12/2000
4	AntigensIBA 01/2001 - 01/2000
3	Bevacizumab (Avastin)FDA Link 01/2021 - 12/2016
3	NivolumabIBA 01/2021 - 12/2016
3	EnzymesIBA 04/2016 - 12/2001
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016 - 09/2000
3	ARQ 197IBA 10/2015 - 06/2013
3	Gemcitabine FDA Link 04/2014 - 06/2004
3	Transforming Growth Factor beta (TGF-beta)IBA 04/2010 - 04/2001
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2006 - 11/2000
3	Immunoglobulin G (IgG)IBA 01/2005 - 04/2000
3	SteroidsIBA 08/2001 - 11/2000
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 01/2001 - 06/2000
2	alectinibIBA 01/2022 - 01/2016
2	Green Fluorescent ProteinsIBA 04/2019 - 02/2009
2	Drug CombinationsIBA 12/2016 - 12/2008
2	AfatinibIBA 11/2016 - 04/2012
2	CarbonIBA 09/2015 - 01/2005
2	MicroRNAs (MicroRNA)IBA 07/2014 - 11/2013
2	Cytochrome P-450 CYP2C19IBA 11/2013 - 06/2013
2	Glycoside Hydrolase InhibitorsIBA 10/2013 - 10/2013
2	Acarbose FDA LinkGeneric 10/2013 - 10/2013
2	ParaffinIBA 06/2013 - 02/2002
2	Histones (Histone)IBA 06/2013 - 11/2012
2	Lysine (L-Lysine)FDA Link 06/2013 - 11/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 01/2001

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 01/2021 - 05/2000
21	Therapeutics 01/2021 - 01/2000
8	Radiotherapy 01/2017 - 09/2000
3	Liver Transplantation 04/2019 - 04/2014
3	Chemoradiotherapy 01/2019 - 05/2000
3	Intravenous Infusions 03/2014 - 09/2000
2	Immunotherapy 08/2021 - 11/2017
2	Neoadjuvant Therapy 01/2019 - 07/2018
2	Transplantation 04/2014 - 10/2005